Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study | Zendy

Maud Koopman | Zendy; Frits M.E. Franssen | Zendy; Swetlana Gaffron | Zendy; Henrik Watz | Zendy; Thierry Troosters | Zendy; Judith GarcíaAymerich | Zendy; Pierluigi Paggiaro | Zendy; Eduard Molins | Zendy; Miguel Moya | Zendy; Lindy van Burk | Zendy; Dieter Maier | Zendy; Esther Garcia Gil | Zendy; Emiel FM Wouters | Zendy; Lowie E.G.W. Vanfleteren | Zendy; Martijn A. Spruit | Zendy

Open Access

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

Author(s) -

Maud Koopman,

Frits M.E. Franssen,

Swetlana Gaffron,

Henrik Watz,

Thierry Troosters,

Judith GarcíaAymerich,

Pierluigi Paggiaro,

Eduard Molins,

Miguel Moya,

Lindy van Burk,

Dieter Maier,

Esther Garcia Gil,

Emiel FM Wouters,

Lowie E.G.W. Vanfleteren,

Martijn A. Spruit

Publication year - 2022

Publication title -

international journal of copd

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 67

eISSN - 1178-2005

pISSN - 1176-9106

DOI - 10.2147/copd.s308600

Subject(s) - medicine , copd , formoterol , placebo , functional residual capacity , physical therapy , randomized controlled trial , lung volumes , minimal clinically important difference , spirometry , crossover study , pulmonary function testing , cardiology , asthma , lung , alternative medicine , pathology , budesonide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research